Skip to main content
Erschienen in: Journal of Cancer Education 3/2015

01.09.2015

A Study on the Knowledge, Perception, and Use of Breast Cancer Screening Methods and Quality of Care Among Women from Central Mexico

verfasst von: Andrea B. Cruz-Castillo, María A. Hernández-Valero, Shelly R. Hovick, Martha Elva Campuzano-González, Miguel Angel Karam-Calderón, L. Patricia Bustamante-Montes

Erschienen in: Journal of Cancer Education | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Studies on health behaviors have observed several barriers to breast cancer screening, including lack of breast cancer knowledge, distrust of health care providers, and long waiting times to be screened or to receive screening results. We conducted a nested case-control study among a subsample of 200 women 21 years of age and older [100 patients (cases)], who had been diagnosed with breast cancer, and 100 controls, who were screened and found to be free of breast cancer), all residing in the Toluca metropolitan area in central Mexico. We examined how knowledge of breast cancer screening guidelines, perceptions of screening methods, and quality of health care influenced the use of breast cancer screening among study participants. Our study found that the most important factor associated with the decision to have breast cancer screenings was having a positive perception of the quality of care provided by the local health care centers, such as having competent clinic personnel, sufficient screening equipment, and reasonable waiting times to receive screening and to receive the screening results. Therefore, individual health care centers need to focus on the patients’ perception of the services received by optimizing the care provided and, in so doing, increase the rates of early diagnosis and reduce the rate of mortality from breast cancer as well as its associated treatment costs.
Literatur
2.
Zurück zum Zitat Knaul FM, Arreola-Ornelas F, Velázquez E, Dorantes J, Méndez O, Ávila-Burgos L (2009) El costo de la atención médica del cáncer mamario: el caso del instituto mexicano del seguro social. Salud Publica Mex 51(2):286–295CrossRef Knaul FM, Arreola-Ornelas F, Velázquez E, Dorantes J, Méndez O, Ávila-Burgos L (2009) El costo de la atención médica del cáncer mamario: el caso del instituto mexicano del seguro social. Salud Publica Mex 51(2):286–295CrossRef
4.
Zurück zum Zitat López-Carrillo L, Suárez-López L, Torres-Sánchez L (2009) Detección del cáncer de mama en México: síntesis de los resultados de la Encuesta Nacional de Salud Reproductiva. Salud Publica Mex 51(2):345–349CrossRef López-Carrillo L, Suárez-López L, Torres-Sánchez L (2009) Detección del cáncer de mama en México: síntesis de los resultados de la Encuesta Nacional de Salud Reproductiva. Salud Publica Mex 51(2):345–349CrossRef
6.
Zurück zum Zitat Feig SA (2006) Screening mammography: a successful public health initiative. Rev Panam Salud Publica 20(2/3):125–133CrossRefPubMed Feig SA (2006) Screening mammography: a successful public health initiative. Rev Panam Salud Publica 20(2/3):125–133CrossRefPubMed
7.
Zurück zum Zitat Lester J (2007) Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Clin J Oncol Nurs 11(5):619–622CrossRefPubMed Lester J (2007) Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Clin J Oncol Nurs 11(5):619–622CrossRefPubMed
8.
Zurück zum Zitat Mahoney MC, Bevers T, Linos E, Willet WC (2008) Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J Clin 58(6):347–371CrossRefPubMed Mahoney MC, Bevers T, Linos E, Willet WC (2008) Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J Clin 58(6):347–371CrossRefPubMed
9.
Zurück zum Zitat Parsa P, Kandiah M, Abdul RH, Zulkefli NM (2006) Barriers for breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev 7(4):509–14PubMed Parsa P, Kandiah M, Abdul RH, Zulkefli NM (2006) Barriers for breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev 7(4):509–14PubMed
10.
Zurück zum Zitat Mohar A, Bargalló E, Ramírez MT, Lara F, Beltrán-Ortega A (2009) Recursos disponibles para el tratamiento del cáncer de mama en México. Salud Publica Mex 51(2):263–269 Mohar A, Bargalló E, Ramírez MT, Lara F, Beltrán-Ortega A (2009) Recursos disponibles para el tratamiento del cáncer de mama en México. Salud Publica Mex 51(2):263–269
11.
Zurück zum Zitat Wall KM, Núñez-Rocha GM, Salinas-Martínez AM, Sánchez-Peña SR (2008) Determinants of the use of breast cancer screening among women workers in urban Mexico. Prev Chronic Dis 5(2):1–8 Wall KM, Núñez-Rocha GM, Salinas-Martínez AM, Sánchez-Peña SR (2008) Determinants of the use of breast cancer screening among women workers in urban Mexico. Prev Chronic Dis 5(2):1–8
12.
Zurück zum Zitat Parsa P, Kandiah M, Zulkefli M, Rahman HA (2008) Knowledge and behavior regarding breast cancer screening among female teachers in Selangor, Malaysia. Asian Pac J Cancer Prev 9(2):221–228PubMed Parsa P, Kandiah M, Zulkefli M, Rahman HA (2008) Knowledge and behavior regarding breast cancer screening among female teachers in Selangor, Malaysia. Asian Pac J Cancer Prev 9(2):221–228PubMed
15.
Zurück zum Zitat Yeboah E, and Thomas M (2009) A cost effective way of reducing outpatient clinic waiting times: how we did it. The Internet Journal of Healthcare Administration. http://ispub.com/IJHCA/. Accessed 28 April 2014 Yeboah E, and Thomas M (2009) A cost effective way of reducing outpatient clinic waiting times: how we did it. The Internet Journal of Healthcare Administration. http://​ispub.​com/​IJHCA/​. Accessed 28 April 2014
19.
Zurück zum Zitat Lee K, Lim HT, Min Park SM (2010) Factors associated with use of breast cancer screening services by women aged ≥40 years in Korea: The Third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III). BioMed Central Cancer. http://www.ncbi.nlm.nih.gov/pubmed/20398358. Accessed 22 April 2014 Lee K, Lim HT, Min Park SM (2010) Factors associated with use of breast cancer screening services by women aged ≥40 years in Korea: The Third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III). BioMed Central Cancer. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​20398358. Accessed 22 April 2014
Metadaten
Titel
A Study on the Knowledge, Perception, and Use of Breast Cancer Screening Methods and Quality of Care Among Women from Central Mexico
verfasst von
Andrea B. Cruz-Castillo
María A. Hernández-Valero
Shelly R. Hovick
Martha Elva Campuzano-González
Miguel Angel Karam-Calderón
L. Patricia Bustamante-Montes
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2015
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0722-y

Weitere Artikel der Ausgabe 3/2015

Journal of Cancer Education 3/2015 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.